![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Visby Medical STI Test gets FDA Clearance
Visby Medical STI Test gets FDA Clearance
March 17, 2023
Visby Medical’s in-office test for sexually-transmitted infections (STIs) in women that delivers 97 percent accurate results in 30 minutes — not the usual two to five days with laboratory testing — just received FDA clearance, enabling diagnosis and treatment in the same office visit.
The San Jose, Calif.-based company’s instrument-free polymerase chain reaction (PCR) diagnostic was cleared by the FDA for detecting Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis.
The rapid test has a Clinical Laboratory Improvement Amendments (CLIA) waiver that allows its use in CLIA-waived point of care settings, enabling clinicians to make informed treatment decisions during a single visit, helping to reduce unnecessary antibiotic use as well as the number of patients lost to care, the company said.
Upcoming Events
-
21Oct